Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
São Paulo med. j ; 140(5): 691-696, Sept.-Oct. 2022. tab, graf
Artículo en Inglés | LILACS-Express | LILACS | ID: biblio-1410216

RESUMEN

ABSTRACT BACKGROUND: Clinical judgment of initial baseline laboratory tests plays an important role in triage and preliminary diagnosis among coronavirus disease 2019 (COVID-19) patients. OBJECTIVES: To determine the differences in laboratory parameters between COVID-19 and COVID-like patients, and between COVID-19 and healthy children. Additionally, to ascertain whether healthy children or patients with COVID-like symptoms would form a better control group. DESIGN AND SETTING: Cross-sectional study at the Institute for Child and Youth Health Care of Vojvodina, Novi Sad, Serbia. METHODS: A retrospective study was conducted on 42 pediatric patients of both sexes with COVID-19. Hematological parameters (white blood cell count, absolute lymphocyte count and platelet count) and biochemical parameters (natremia, kalemia, chloremia, aspartate aminotransferase [AST], alanine aminotransferase [ALT], lactate dehydrogenase [LDH] and C-reactive protein [CRP]) were collected. The first control group was formed by 80 healthy children and the second control group was formed by 55 pediatric patients with COVID-like symptoms. RESULTS: Leukocytosis, lymphopenia, thrombocytosis, elevated systemic inflammatory index and neutrophil-lymphocyte ratio, hyponatremia, hypochloremia and elevated levels of AST, ALT, LDH and CRP were present in COVID patients, in comparison with healthy controls, while in comparison with COVID-like controls only lymphopenia was determined. CONCLUSIONS: The presence of leukocytosis, lymphopenia, thrombocytosis, elevated systemic inflammatory index and neutrophil-lymphocyte ratio, hyponatremia, hypochloremia and elevated levels of AST, ALT, LDH and CRP may help healthcare providers in early identification of COVID-19 patients. Healthy controls were superior to COVID-like controls since they provided better insight into the laboratory characteristics of children with novel betacoronavirus (SARS-CoV-2) infection.

2.
J Biosci ; 2019 Sep; 44(4): 1-12
Artículo | IMSEAR | ID: sea-214169

RESUMEN

It has been proposed that age reprogramming enables old cells to be rejuvenated without passage through an embryonicstage (Singh and Zacouto in J. Biosci. 35 315–319, 2010). As such, age reprogramming stands apart from the inducedpluripotent stem (iPS) and nuclear transfer-embryonic stem (NT-ES) cell therapies where histo-compatible cells are produced only after passage through an embryonic stage. It avoids many of the disadvantages associated with iPS and NT-EScell therapies. Experimental evidence in support of age reprogramming is burgeoning. Here, we discuss possible newapproaches to enhance age reprogramming, which will have considerable benefits for regenerative therapies.

3.
Acta biol. colomb ; 21(3): 467-472, set.-dic, 2016. ilus, tab
Artículo en Español | LILACS | ID: biblio-827624

RESUMEN

For over five decades the dominant neo-Darwinian view is that natural selection acts only at the genic and organismal levels, but the ignored empirical evidence of multilevel selection occurring in nature obtained over the last fifty years does not agree with it. A long exchange of mathematical and theoretical arguments about the levels at which natural selection acts constitutes what is known as the 'levels of selection debate'. The large amount of empirical evidence, studied by quantitative genetics means, specifically contextual analysis, indicates that natural selection acts on levels of the biological hierarchy above and below that of the gene and organism, from the molecular to the ecosystem level, thus supporting what is called the multilevel selection theory. Beyond theoretical arguments, if empirical evidence for multilevel selection and contextual analysis results are carefully examined, the debate on the levels of selection is easily resolved: natural selection occurs in nature at different levels of biological hierarchy. This text provides an overview of such empirical evidence.


Por más de cinco décadas la visión neo-darwinista dominante de la selección natural es que esta actúa únicamente a nivel génico y organísmico, pero la ignorada evidencia empírica de selección multinivel ocurriendo en la naturaleza obtenida durante los últimos cincuenta años no es consecuente. Un largo intercambio de argumentaciones matemáticas y teóricas sobre los niveles en los que actúa la selección natural constituye lo que se denomina como el "debate de los niveles de selección". La gran cantidad de evidencia empírica, estudiada mediante métodos de genética cuantitativa, específicamente el análisis contextual, indica que la selección natural actúa en niveles de la jerarquía biológica por encima y por debajo del nivel del gen y organismo, desde el nivel molecular hasta el ecosistémico, apoyando así lo que se denomina la teoría de selección multinivel. Más allá de argumentos teóricos, si se examina cuidadosamente la evidencia empírica de selección multinivel y los resultados del análisis contextual, se resuelve de forma sencilla el debate de los niveles de selección: la selección natural ocurre en la naturaleza en diferentes niveles de la jerarquía biológica. Este texto ofrece una revisión general de dicha evidencia empírica.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA